Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2554521rdf:typepubmed:Citationlld:pubmed
pubmed-article:2554521lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:2554521lifeskim:mentionsumls-concept:C0002191lld:lifeskim
pubmed-article:2554521lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:2554521lifeskim:mentionsumls-concept:C0483249lld:lifeskim
pubmed-article:2554521pubmed:issue2lld:pubmed
pubmed-article:2554521pubmed:dateCreated1989-12-18lld:pubmed
pubmed-article:2554521pubmed:abstractTextInactivation of activated protein C (APC) in normal human plasma was studied in the absence and presence of heparin. In the absence of heparin APC inactivation followed pseudo-first order kinetics. In the presence of heparin the neutralization of APC was found to be biphasic. Up to 500 nM APC could be readily inactivated in normal plasma, indicating that the concentration of the APC inhibitor must be higher than previously assumed. Plasma deficient in the protein C inhibitor (PCI-I, as described by Suzuki and coworkers) and deficient in beta 2-glycoprotein I still possessed APC neutralizing capacity, presumably through the formation of complexes of APC with another plasma protein as was demonstrated by immunoblotting with anti-protein C antibodies. Together these data made us to conclude that a second inhibitor of APC (PCI-II) must be present in normal human plasma. This second inhibitor should be heparin independent, have a relatively high plasma concentration and form complexes with APC. Subsequently, we purified this PCI-II by isolating APC-PCI-II complexes from plasma deficient of vitamin K dependent proteins, PCI-I and beta 2-glycoprotein-I, to which purified human APC had been added. Purified PCI-II has a molecular weight of 50,000 daltons and aminoacid analysis revealed that PCI-II is identical with alpha 1-antitrypsin (alpha 1-AT). The second order rate constant for the reaction between purified alpha 1-AT and APC was found to be 269 M-1 min-1 in the absence of calcium and 602 M-1 min-1 in the presence of calcium.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:2554521pubmed:languageenglld:pubmed
pubmed-article:2554521pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2554521pubmed:citationSubsetIMlld:pubmed
pubmed-article:2554521pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2554521pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2554521pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2554521pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2554521pubmed:statusMEDLINElld:pubmed
pubmed-article:2554521pubmed:monthSeplld:pubmed
pubmed-article:2554521pubmed:issn0340-6245lld:pubmed
pubmed-article:2554521pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:2554521pubmed:authorpubmed-author:BriëtEElld:pubmed
pubmed-article:2554521pubmed:authorpubmed-author:BertinaR MRMlld:pubmed
pubmed-article:2554521pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:2554521pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:2554521pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:2554521pubmed:issnTypePrintlld:pubmed
pubmed-article:2554521pubmed:day29lld:pubmed
pubmed-article:2554521pubmed:volume62lld:pubmed
pubmed-article:2554521pubmed:ownerNLMlld:pubmed
pubmed-article:2554521pubmed:authorsCompleteYlld:pubmed
pubmed-article:2554521pubmed:pagination756-62lld:pubmed
pubmed-article:2554521pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2554521pubmed:meshHeadingpubmed-meshheading:2554521-...lld:pubmed
pubmed-article:2554521pubmed:meshHeadingpubmed-meshheading:2554521-...lld:pubmed
pubmed-article:2554521pubmed:meshHeadingpubmed-meshheading:2554521-...lld:pubmed
pubmed-article:2554521pubmed:meshHeadingpubmed-meshheading:2554521-...lld:pubmed
pubmed-article:2554521pubmed:meshHeadingpubmed-meshheading:2554521-...lld:pubmed
pubmed-article:2554521pubmed:meshHeadingpubmed-meshheading:2554521-...lld:pubmed
pubmed-article:2554521pubmed:meshHeadingpubmed-meshheading:2554521-...lld:pubmed
pubmed-article:2554521pubmed:meshHeadingpubmed-meshheading:2554521-...lld:pubmed
pubmed-article:2554521pubmed:year1989lld:pubmed
pubmed-article:2554521pubmed:articleTitleA second plasma inhibitor of activated protein C: alpha 1-antitrypsin.lld:pubmed
pubmed-article:2554521pubmed:affiliationDept. of Haematology, University Hospital Leiden, The Netherlands.lld:pubmed
pubmed-article:2554521pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2554521lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2554521lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2554521lld:pubmed